The free wall was moderately hypertrophic (5 mm).
There were 17 patients in whom the diagnosis was shown to be primary hypertrophic cardiomyopathy.
To date, no data are available on the efficacy of this drug in infants with hypertrophic cardiomyopathy.
A total of 22 patients were studied, 17 with primary hypertrophic cardiomyopathy.
We have referred to these as 'secondary' to distinguish them from our patients with isolated hypertrophic cardiomyopathy.
A significant association between prenatal hypertrophic cardiomyopathy and fetal hyperinsulinism was demonstrated (p<0 007).
We describe the clinical profile of 35 patients with hypertrophic cardiomyopathy, 18 being younger than 1 year when first seen.
There was no family history of congenital heart disease or hypertrophic cardiomyopathy, even by echocardiography.
